Q&A: Geisinger CSO David Ledbetter on Making Genomics Valuable for Healthcare Organizations
January 11, 2011
Q&A: Geisinger CSO David Ledbetter on Making Genomics Valuable for Healthcare Organizations
BioArray News spoke with Ledbetter about his new role at Geisinger, as well as the continued activities of the International Standards for Cytogenomic Arrays Consortium.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- ISCA Changes Name to be More Inclusive of Sequencing Community, Clinical Geneticists
October 23, 2012 / BioArray News - Agilent Provides Update on FDA Discussions for Cyto Arrays, Posts 8 Percent Rise in Fiscal Q1 Revenues
February 21, 2012 / BioArray News - Lineagen Targeting Pediatricians with New Chromosomal Microarray Testing Service
January 11, 2011 / BioArray News - BlueGnome Expands 24sure IVF Play with New Kit for Studying Miscarriage
December 7, 2010 / BioArray News - People in the News
November 9, 2010 / BioArray News